What PhytoPr-Bio does

PhytoPur Bio Spółka z o.o. (operating under the PhytoPr-Bio / PhytoPur Bio brand) is a privately held Polish company registered in Warsaw (al. Jana Pawła II 27; KRS 0000968820, NIP 5213970446, REGON 522168280) that operates an educational platform dedicated to the medical applications of cannabis. The platform is purpose-built for licensed physicians in Poland and gates content behind a two-step verification process requiring a valid PWZ (Polish medical license) number and a formal legal attestation of active registration with the relevant Okręgowa Rada Lekarska (regional medical chamber), in compliance with the Polish Pharmaceutical Law (Prawo farmaceutyczne) which restricts specialist medical information and pharmaceutical product advertising to authorized healthcare professionals.

The core product is a gated web portal at phytopurbio.pl intended to host specialist content on cannabinoid therapeutics. At the time of review the site displays a "Materiał dostępny wkrótce" (material coming soon) placeholder, indicating a pre-launch or early-stage content state rather than a fully populated destination. No mobile applications, APIs, SDKs, third-party integrations, or proprietary technology stack are disclosed; the site is built on a standard WordPress content management layer. No product SKUs, pricing tiers, or monetisation mechanisms are publicly listed, and the company discloses no ownership composition, management team, funding history, or commercial partnerships.

The business model and revenue mechanics are not articulated in any available source. PhytoPur Bio appears to operate as a thin regulated-content vehicle: a single-vertical medical information provider with a Poland-only footprint, no disclosed monetisation layer, and no documented customers beyond the implicit end-user cohort of registered Polish physicians. Note that the firmographics metadata describing PhytoPr-Bio as a UK-based CBD-infused product manufacturer in London conflicts with the detailed primary-source records (Warsaw registration, medical education focus, KRS/NIP identifiers); this analysis treats the Warsaw-registered medical education entity as authoritative per first-party-source precedence.

Name

PhytoPr-Bio

Legal name

PhytoPur Bio Spółka z o.o.

Website

https://phytopurbio.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

PhytoPur Bio Spółka z o.o. is a Warsaw-registered Polish company operating a gated-access educational platform on medical cannabis applications, serving exclusively licensed Polish physicians under Polish Pharmaceutical Law compliance with PWZ-verified login.

Ownership category

akta.pro rank

Product category

Medical Cannabis Education for Healthcare Professionals

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

• Medical cannabis education
• Pharmaceutical compliance platform
• Healthcare professional content
• Medical information services
• Continuing physician education

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

PhytoPr-Bio operates a restricted-access online educational platform (phytopurbio.pl) delivering specialist medical information on the therapeutic use of cannabis. Access is gated behind verification of a valid Polish physician license (PWZ) and an attestation of active registration with the relevant regional medical council (Okręgowa Rada Lekarska), in compliance with Polish Pharmaceutical Law (Prawo farmaceutyczne). The platform content is currently pending release ("Materiał dostępny wkrótce").

Product overview

PhytoPr-Bio (PhytoPur Bio Spółka z. o. o.) operates an educational platform dedicated to the medical use of cannabis, designed exclusively for licensed medical professionals. The platform provides specialized medical information accessible only to doctors with valid PWZ (Polish medical license) numbers who are registered with their regional medical association and not suspended from practice. Access is restricted under Poland's Pharmaceutical Law (Prawo farmaceutyczne) which limits specialist medical information to authorized healthcare professionals only.

Differentiator

Problem solved

Functional benefit

Products and services

• PhytoPr-Bio Medical Cannabis Education Platform A restricted-access online educational platform providing specialist medical information on cannabis applications, intended exclusively for licensed medical doctors in Poland who hold an active PWZ number and are registered with the relevant regional medical chamber.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• Charlotte's Web: Leading CBD product manufacturer offering oils, topicals, gummies, and other hemp-derived CBD products. Comparable to PhytoPur Bio's stated CBD product manufacturing operations across body care, oils, face care, and cleansing products.
• Endoca: Established CBD manufacturer producing oils, capsules, and topicals from hemp. Comparable to PhytoPur Bio's described CBD-infused product manufacturing business, though at much larger global scale.
• Elixinol: Global CBD product manufacturer offering a range of hemp-derived CBD wellness products. Comparable to PhytoPur Bio's described CBD product manufacturing focus across multiple personal care categories.
• Canopy Growth: Major global cannabis company with medical cannabis and CBD product lines across multiple geographies including Europe. Comparable to PhytoPur Bio's combined medical cannabis and CBD focus, though operating at substantially larger scale and across broader jurisdictions.
• Tilray: Global cannabis company with significant medical cannabis operations in Europe, including EU-GMP certified production. Comparable to PhytoPur Bio's medical cannabis and CBD orientation, though at much larger scale and with established European distribution.

Direct peers

• The Cannigma: Science-based cannabis information and education resource covering medical cannabis applications and clinical evidence. Directly comparable in mission and content category to PhytoPur Bio's medical cannabis educational platform.
• Medical Marijuana 411: Offers cannabis education courses and certification for medical professionals and patients. Comparable to PhytoPur Bio's regulated, clinician-focused medical cannabis education platform.
• Cannabis Training Institute: Provides cannabis education and certification programs targeted at medical professionals and industry workers. Directly comparable to PhytoPur Bio's medical cannabis educational platform for licensed physicians, with the same clinician-facing content model.
• Marijuana Doctors: Medical cannabis platform connecting patients with physicians and providing cannabis-related clinician education. Comparable to PhytoPur Bio's HCP-facing medical cannabis platform model, with overlap in audience and content category.
• Healer: Provides cannabis education and training programs specifically designed for healthcare professionals and patients. Closely comparable to PhytoPur Bio's gated HCP-focused medical cannabis content model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PhytoPr-Bio